Therapeutic advances in pediatric multiple sclerosis

J Pediatr. 2013 Sep;163(3):631-7. doi: 10.1016/j.jpeds.2013.04.028. Epub 2013 May 30.
No abstract available

Keywords: FDA; Food and Drug Administration; IFN; Interferon; JC; John Cunningham; MRI; MS; Magnetic resonance imaging; Multiple sclerosis; PML; Progressive multifocal leukoencephalopathy; T helper; Th.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / etiology
  • Risk Factors
  • Vitamin D Deficiency / complications

Substances

  • Adjuvants, Immunologic
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors